Medication info
Combi Forge 5/160 mg

Combi Forge 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Kolon Pharmaceutical Co., Ltd.
Appearance
Dark yellow oblong film-coated tablet
Packaging
28 tablets/PTP (14 tablets/PTP × 2)
Approval status
Active

MFDS item code 201308459 · Approved 2013.07.30 · Insurance code 670303690

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this drug may be considered. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Kolon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension when blood pressure is not adequately controlled by amlodipine or valsartan alone. It helps effectively lower and control blood pressure by using two components together. By managing blood pressure reliably, it reduces the risk of cardiovascular complications and contributes to overall health improvement.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this drug may be considered. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during the second and third trimester of pregnancy; hence, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the main components of this medication or similar ingredients, pregnant or breastfeeding women, patients with severe kidney or liver disease, and those with specific heart conditions should not take this medication. Patients with a deficiency of sodium or water in the body, high potassium levels, kidney issues, organ transplant recipients, and those with a history of angioedema should take this medication with caution and consult a doctor immediately if any abnormal symptoms occur. Possible side effects when taking this medication include headaches, dizziness, swelling, lowered blood pressure, and skin rashes, with rare occurrences of serious allergies or angioedema, so caution is necessary. Be careful while driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other blood pressure medications, potassium-sparing diuretics, and certain anti-inflammatory drugs (NSAIDs). Always inform your doctor or pharmacist of any medications being taken together. Pregnant women or those planning to become pregnant should not use this medication, and breastfeeding mothers are also advised against using it. Children under 18 years old should not use this medication as its safety and efficacy have not been adequately established. In case of an overdose, blood pressure may drop excessively, so seek appropriate treatment immediately if symptoms arise. It is important to regularly monitor blood pressure, kidney function, and serum electrolyte levels during the use of this medication to check for any abnormalities.

Side effects

pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the throat and larynx, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle cramps, weakness, frequent urination, polyuria, erectile dysfunction, edema, peripheral edema, facial swelling, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, reduced hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory reduction, ageusia, peripheral neuropathy, hypertonic muscle syndrome, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photodermatitis, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, nervous irritation, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is advisable to keep it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow oblong film-coated tablet

Package unit

28 tablets/PTP (14 tablets/PTP × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.